Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts.
All companies · Product and company coverage
In 2025, Reprise Biomedical reported engagement with 1,425 surgeons and other clinicians in the states MedaRep covers, worth $202K in consulting, speaking, meals and travel for its device products, the most in Florida ($125K to 171). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Florida ($125K, 171 engaged), Georgia ($20K, 30 engaged), Missouri ($16K, 26 engaged), North Carolina ($3,550, 24 engaged), Washington ($3,247, 13 engaged).
In the last ten years FDA made 5 decisions for Reprise Biomedical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (2). The latest was on 2024-04-19.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 5 |
| Miro3D Wound Matrix |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Reprise Biomedical.